Prognostic and predictive implications of the intrinsic subtypes and gene expression signatures in early-stage HER2+ breast cancer: A pooled analysis of CALGB 40601, NeoALTTO, and NSABP B-41 trials.
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Aranzazu Fernandez-Martinez, Mattia Rediti, Gong Tang, Tomas Pascual, Katherine A. Hoadley, David Venet, Naim Rashid, Patricia Spears, Md N. Islam, Sarra El-Abed, Judith Bliss, Matteo Lambertini, Jens Bodo Huober, David Goerlitz, Rong Hu, Peter C. Lucas, Sandra M. Swain, Christos Sotiriou, Charles M. Perou, Lisa A. Carey
Institutions: University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Université Libre de Bruxelles, Institut Jules Bordet, University of Pittsburgh, Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Georgetown University Medical Center, Breast International Group, Institute of Cancer Research, Ospedale Policlinico San Martino, Kantonsspital St. Gallen, Georgetown Lombardi Comprehensive Cancer Center
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4281988024